Multicenter Double-Blind Randomized Controlled Trial to Evaluate the Effectiveness and Safety of Bortezomib as a Treatment for Refractory Systemic Lupus Erythematosus.
| Author | |
|---|---|
| Abstract | :
To evaluate the efficacy and safety of bortezomib for treating systemic lupus erythematosus (SLE), in patients whose disease activity could not be controlled. |
| Year of Publication | :
2018
|
| Journal | :
Modern rheumatology
|
| Number of Pages | :
1-20
|
| Date Published | :
2018
|
| ISSN Number | :
1439-7595
|
| URL | :
http://www.tandfonline.com/doi/full/10.1080/14397595.2018.1432331
|
| DOI | :
10.1080/14397595.2018.1432331
|
| Short Title | :
Mod Rheumatol
|
| Download citation |